Mountain View, California, United States
Reliant Technologies, Inc. announced today that it has received multiple approvals in the Asia Pacific region for the commercial sale of the Fraxel SR1500 laser, the latest innovation in aesthetic laser medical technology. This extension of the Fraxel line of skin resurfacing products has regulatory authorization for commercial sale in the following countries: Australia, New Zealand, Indonesia, Vietnam, Malaysia, Hong Kong, Japan, and the Philippines. Clearance approvals are also expected in the following countries later this year: Korea, Singapore, Taiwan, and Thailand.
These approvals pave the way for Reliant to market its latest technology, throughout the world, and throughout Asia Pacific, for the treatment of pigmented lesions, melasma, periorbital wrinkles, acne scars, surgical scars, skin resurfacing and soft tissue coagulation.
The Fraxel SR1500 laser combines proprietary advancements in optical technology with medical software offering physicians a treatment option that penetrates up to 30 percent deeper, delivering consistent dosage control and optimising lesion depths with spot size determined by indication. This leap in technology provides patients a best-in-class, safe and effective, non-invasive treatment option for skin conditions ranging from mild sun damage to severe acne scarring.
Eric Stang, president and CEO of Reliant Technologies, said the continued development of the family of Fraxel lasers responds to a rapidly growing consumer demand for safe, effective and predictable skin treatment options.
"Whether we suffer from serious skin problems or simply want to feel better about how we look as we age, we want options. We want a treatment we know delivers results with the least amount of recovery time and the lowest risk of side effects," said Stang.
"For the Fraxel SR1500 laser our engineers and scientists set out to accomplish two breakthrough goals," Stang added. "First, we wanted to achieve maximum efficiency in dosage control. Second, we wanted to optimise the lesion we deliver. In our continued efforts to invest in best practices, we have a product that enables physicians to deliver both consistent dosage control and optimal lesion depth resulting in a predictable treatment for every patient every time."
The Fraxel SR1500 laser marks the first expansion of the Fraxel family of lasers, launched in autumn 2004. With the initial launch, Reliant created a new category in anti-aging, collagen remodeling and skin resurfacing. The product provides a highly effective, predictable and safe non-ablative treatment for patients with acne scarring, melasma or hormonal skin discoloration, periorbital wrinkles and sun and age spots. The launch of the Fraxel laser represented an industry breakthrough for its ability to penetrate fractions of skin, spot by spot, without breaking the skin's protective outer barrier. The result is natural stimulation of new collagen without the fear of downtime and risks associated with traditional ablative treatments.
The new launch brings to market another breakthrough in aesthetic skin treatment by optimising the laser delivery technology and accompanying medical software. With the newly designed Optical Zoom hand control system, for the first time physicians can penetrate up to 1.0 millimeters below the skin surface with precise dosage control. Deeper penetration provides a greater catalyst for natural generation of new collagen to promote self healing and remodeling.
Fraxel SR1500 laser features and benefits include:
-- Telescoping zoom lens that allows the software to automaticallyoptimise lesion depth
-- Minimizes unnecessary bulk heating of the skin, reducing side-effects such as hyper-pigmentation
-- Dosage control
-- Allows the physician to choose the optimal treatment plan for the patient
-- A smart treatment control engine
-- Calculates the depth of penetration and dosage delivery based on physicians' selection of energy and treatment level
-- A lighter ergonomic hand piece
-- Provides greater ease of use to the physician
-- Enhanced tracking performance (30x faster updates)
-- Provides smooth, consistent, uniform pattern delivery
-- New operating system with an expandable and upgradeable platform
-- Supports future enhancements
-- Redesigned high-resolution graphic user interface with new software engine
-- Providing real-time measurement data, requiring no more calculations, graphs or look up tables by the physician
The new software engine is driven by a sophisticated algorithm that allows the physician to optimise or more precisely focus on specific areas of repair while controlling the collimated depth of penetration. This algorithm refers to a database populated with data from thousands of histology slides that determines the most appropriate lesion depth and width based on the settings selected by the physician. The result is a greater ability to customise treatment to the one, or in many cases, several different areas of concern for each patient with the touch of a button.
"The Fraxel laser is effective for facial, neck and chest rejuvenation and acne scars because of the characteristic changes that it induces in the skin with microthermal zones of injury followed by repair," said Dr. Zakia Rahman, clinical instructor of dermatology at Stanford University, Palo Alto, CA, USA. "The Fraxel laser is particularly appealing when treating Asian or similarly pigmented skin, as the laser targets water, not melanin, thus avoiding the risk of hyper-pigmentation. Recent studies have shown Fraxel SR laser treatments to be safe, reproducible and effective in all skin types."
Dr. Rahman has led several FDA clinical studies with the Fraxel laser, "We have seen enhanced clinical efficacy in clinical evaluations of the Fraxel SR 1500 laser," she explained. "Patients noted a comfortable treatment with virtually no interruption in their daily activities."
Notes to Editor:
About the Fraxel Lasers and Reliant Technologies
Reliant Technologies develops clinical solutions to repair and rejuvenate aging and environmentally damaged skin. Reliant is dedicated to providing the most advanced research, engineering and products to the global aesthetic marketplace. The Company's laser device is used primarily by aesthetic physicians to treat periorbital wrinkles, pigmented lesions and photo-damaged skin of the face and body. Reliant pioneered the development of fractional laser resurfacing which relies on novel high speed scanning systems and the Intelligent Optical Tracking(TM)system to produce safe and effective results with minimal recovery time. Reliant is headquartered in Mountain View, California. For more information and physician referrals, visit www.fraxel.com.
The Fraxel laser family has quickly become the industry standard for aesthetic laser skin treatment. Because of its gentle, non-invasive approach to skin resurfacing, Fraxel lasers are safe and effective in treating all skin types and all areas of the face and body. The Fraxel laser has also received clearance from the US Food and Drug Administration (FDA) for treatment of pigmented lesions, melasma, periorbital wrinkles, acne scars, surgical scars, skin resurfacing and soft tissue coagulation.
CONTACT: Reliant Technologies, Inc. Michael Hromadik 650-641-5828 mhromadik@reliant-tech.com or GCI Group Lindsay Caulfield 310-526-5591 lcaulfield@gcigroup.com
Source: Business Wire (Business Wire India)